ReviewChirurgie (Heidelberg, Germany)2026
[Local regrowth: what are the surgical options?]
Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The different treatment concepts for rectal cancer are in a continuous state of change and were recently summarized and presented in the updated German S3 guidelines. While organ preservation is of increasing importance in the clinical routine, modern multimodal total neoadjuvant treatment strategies can achieve complete and nearly complete response rates of up to 50%. For these patients this subsequently means the necessity for close monitoring models in a watch-and-wait concept, whereby various studies have now shown local recurrence rates of25-30% within the first 2 years. Due to increasing implementation of effective total neoadjuvant treatment concepts and the accompanying increasing incidence of local recurrence after initial complete response, the question of the optimal treatment regimen in these situations increasingly arises. This article summarizes the current evidence in this context and presents an interdisciplinary treatment algorithm.
Indexed as
Identifiers
41876756What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.